Promimic AB
Promimic AB (publ) manufactures, markets, and sells biomaterials for improved osseointegration for orthopedic and dental implants markets. It offers HAnano surface technology that combines various properties that are known to improve osseointegration into one unique surface modification. The company was incorporated in 2004 and is based in Mölndal, Sweden.
Promimic AB (PRO) - Total Liabilities
Latest total liabilities as of December 2025: Skr16.60 Million SEK
Based on the latest financial reports, Promimic AB (PRO) has total liabilities worth Skr16.60 Million SEK as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Promimic AB - Total Liabilities Trend (2018–2025)
This chart illustrates how Promimic AB's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Promimic AB Competitors by Total Liabilities
The table below lists competitors of Promimic AB ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Gauzy Ltd. Ordinary Shares
NASDAQ:GAUZ
|
USA | $118.95 Million |
|
Taiwan Thick-Film Ind
TWO:6246
|
Taiwan | NT$828.96 Million |
|
BioMark Diagnostics Inc
PINK:BMKDF
|
USA | $1.97 Million |
|
Havila Shipping ASA
OL:HAVI
|
Norway | Nkr1.17 Billion |
|
Shengfeng Development Limited Class A Ordinary Shares
NASDAQ:SFWL
|
USA | $166.27 Million |
|
Garuda Maintenance Facility AeroAsia Tbk PT
JK:GMFI
|
Indonesia | Rp658.98 Million |
|
Paringa Resources Limited
PINK:PNGZF
|
USA | $1.26 Million |
|
Bicycle Therapeutics plc
F:50BA
|
Germany | €145.47 Million |
Liability Composition Analysis (2018–2025)
This chart breaks down Promimic AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.53 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.28 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Promimic AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Promimic AB (2018–2025)
The table below shows the annual total liabilities of Promimic AB from 2018 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | Skr16.60 Million | -8.53% |
| 2024-12-31 | Skr18.15 Million | +12.36% |
| 2023-12-31 | Skr16.16 Million | +41.03% |
| 2022-12-31 | Skr11.46 Million | +19.40% |
| 2021-12-31 | Skr9.60 Million | +31.93% |
| 2020-12-31 | Skr7.27 Million | +9.83% |
| 2019-12-31 | Skr6.62 Million | -8.43% |
| 2018-12-31 | Skr7.23 Million | -- |